Wellington Management Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $294K | Sell |
|
|||||
|
2025
Q1 | $2.12M | Sell |
|
|||||
|
2024
Q4 | $4.1M | Buy |
|
|||||
|
2024
Q3 | $3.28M | Sell |
|
|||||
|
2024
Q2 | $3.03M | Sell |
|
|||||
|
2024
Q1 | $3.37M | Sell |
|
|||||
|
2023
Q4 | $2.66M | Sell |
|
|||||
|
2023
Q3 | $3.51M | Buy |
|
|||||
|
2023
Q2 | $1.82M | Buy |
|
|||||
|
2023
Q1 | $1.73M | Buy |
|
|||||
|
2022
Q4 | $176K | Hold |
|
|||||
|
2022
Q3 | $156K | Sell |
|
|||||
|
2022
Q2 | $153K | Sell |
|
|||||
|
2022
Q1 | $294K | Hold |
|
|||||
|
2021
Q4 | $251K | Hold |
|
|||||
|
2021
Q3 | $305K | Buy |
|
|||||
|
2021
Q2 | $219K | Sell |
|
|||||
|
2021
Q1 | $763K | Buy |
|
|||||
|
2020
Q4 | $574K | Sell |
|
|||||
|
2020
Q3 | $620K | Buy |
|
|||||
|
2020
Q2 | $252K | Buy |
|
|||||
|
2020
Q1 | $132K | Sell |
|
|||||
|
2019
Q4 | $761M | Buy |
|
|||||
|
2019
Q3 | $523M | Buy |
|
|||||
|
2019
Q2 | $581M | Buy |
|
|||||
|
2019
Q1 | $917M | Buy |
|
|||||
|
2018
Q4 | $695M | Buy |
|
|||||
|
2018
Q3 | $830M | Buy |
|
|||||
|
2018
Q2 | $731M | Sell |
|
|||||
|
2018
Q1 | $659M | Sell |
|
|||||
|
2017
Q4 | $903M | Buy |
|
|||||
|
2017
Q3 | $621M | Buy |
|
|||||
|
2017
Q2 | $809M | Buy |
|
|||||
|
2017
Q1 | $567M | Buy |
|
|||||
|
2016
Q4 | $430M | Buy |
|
|||||
|
2016
Q3 | $446M | Buy |
|
|||||
|
2016
Q2 | $452M | Buy |
|
|||||
|
2016
Q1 | $471M | Buy |
|
|||||
|
2015
Q4 | $406M | Buy |
|
|||||
|
2015
Q3 | $9.03M | Sell |
|
|||||
|
2015
Q2 | $231M | Sell |
|
|||||
|
2015
Q1 | $441M | Sell |
|
|||||
|
2014
Q4 | $595M | Sell |
|
|||||
|
2014
Q3 | $588M | Sell |
|
|||||
|
2014
Q2 | $735M | Sell |
|
|||||
|
2014
Q1 | $1.71B | Sell |
|
|||||
|
2013
Q4 | $1.82B | Sell |
|
|||||
|
2013
Q3 | $2.23B | Sell |
|
|||||
|
2013
Q2 | $2.4B | Buy |
|